APO Research
Talk to an analyst

APO RESEARCH · REPORT

FAPI for Tumor Treatment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global FAPI for Tumor Treatment Market Analysis and Forecast 2026-2032

29 December 2025192 pages

Choose your research edition.

Industry ResearchFAPI for Tumor Treatment Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal FAPI for Tumor Treatment Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal FAPI for Tumor Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal FAPI for Tumor Treatment Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal FAPI for Tumor Treatment Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global FAPI for Tumor Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for FAPI for Tumor Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for FAPI for Tumor Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for FAPI for Tumor Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for FAPI for Tumor Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of FAPI for Tumor Treatment include Clovis Oncology, Bayer and Novartis AG, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for FAPI for Tumor Treatment, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of FAPI for Tumor Treatment, also provides the sales of main regions and countries. Of the upcoming market potential for FAPI for Tumor Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the FAPI for Tumor Treatment sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global FAPI for Tumor Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for FAPI for Tumor Treatment sales, projected growth trends, production technology, application and end-user industry.

FAPI for Tumor Treatment Segment by Company

Clovis Oncology

Bayer

Novartis AG

FAPI for Tumor Treatment Segment by Type

Beta-emitter

Alpha-emitter

FAPI for Tumor Treatment Segment by Application

NSCLC

Pancreatic Cancer

Breast Cancer

Others

FAPI for Tumor Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global FAPI for Tumor Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of FAPI for Tumor Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of FAPI for Tumor Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of FAPI for Tumor Treatment in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of FAPI for Tumor Treatment manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, FAPI for Tumor Treatment sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global FAPI for Tumor Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Beta-emitter Major Manufacturers Table 3. Alpha-emitter Major Manufacturers Table 4. Global FAPI for Tumor Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. NSCLC Major Manufacturers Table 6. Pancreatic Cancer Major Manufacturers Table 7. Breast Cancer Major Manufacturers Table 8. Others Major Manufacturers Table 9. FAPI for Tumor Treatment Industry Trends Table 10. FAPI for Tumor Treatment Industry Drivers Table 11. FAPI for Tumor Treatment Industry Opportunities and Challenges Table 12. FAPI for Tumor Treatment Industry Restraints Table 13. Global FAPI for Tumor Treatment Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global FAPI for Tumor Treatment Revenue by Region (2021-2026) & (US$ Million) Table 15. Global FAPI for Tumor Treatment Revenue by Region (2027-2032) & (US$ Million) Table 16. Global FAPI for Tumor Treatment Revenue Market Share by Region (2021-2026) Table 17. Global FAPI for Tumor Treatment Revenue Market Share by Region (2027-2032) Table 18. Global FAPI for Tumor Treatment Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global FAPI for Tumor Treatment Sales by Region (2021-2026) & (K Units) Table 20. Global FAPI for Tumor Treatment Sales by Region (2027-2032) & (K Units) Table 21. Global FAPI for Tumor Treatment Sales Market Share by Region (2021-2026) Table 22. Global FAPI for Tumor Treatment Sales Market Share by Region (2027-2032) Table 23. Global FAPI for Tumor Treatment Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global FAPI for Tumor Treatment Revenue Market Share by Manufacturers (2021-2026) Table 25. Global FAPI for Tumor Treatment Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global FAPI for Tumor Treatment Sales Market Share by Manufacturers (2021-2026) Table 27. Global FAPI for Tumor Treatment Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global FAPI for Tumor Treatment Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global FAPI for Tumor Treatment Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global FAPI for Tumor Treatment Manufacturers, Product Type & Application Table 31. Global FAPI for Tumor Treatment Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global FAPI for Tumor Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global FAPI for Tumor Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global FAPI for Tumor Treatment Revenue by Type (2021-2026) & (US$ Million) Table 36. Global FAPI for Tumor Treatment Revenue by Type (2027-2032) & (US$ Million) Table 37. Global FAPI for Tumor Treatment Revenue Market Share by Type (2021-2026) Table 38. Global FAPI for Tumor Treatment Revenue Market Share by Type (2027-2032) Table 39. Global FAPI for Tumor Treatment Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global FAPI for Tumor Treatment Sales by Type (2021-2026) & (K Units) Table 41. Global FAPI for Tumor Treatment Sales by Type (2027-2032) & (K Units) Table 42. Global FAPI for Tumor Treatment Sales Market Share by Type (2021-2026) Table 43. Global FAPI for Tumor Treatment Sales Market Share by Type (2027-2032) Table 44. Global FAPI for Tumor Treatment Price by Type (2021-2026) & (US$/Unit) Table 45. Global FAPI for Tumor Treatment Price by Type (2027-2032) & (US$/Unit) Table 46. Global FAPI for Tumor Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global FAPI for Tumor Treatment Revenue by Application (2021-2026) & (US$ Million) Table 48. Global FAPI for Tumor Treatment Revenue by Application (2027-2032) & (US$ Million) Table 49. Global FAPI for Tumor Treatment Revenue Market Share by Application (2021-2026) Table 50. Global FAPI for Tumor Treatment Revenue Market Share by Application (2027-2032) Table 51. Global FAPI for Tumor Treatment Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global FAPI for Tumor Treatment Sales by Application (2021-2026) & (K Units) Table 53. Global FAPI for Tumor Treatment Sales by Application (2027-2032) & (K Units) Table 54. Global FAPI for Tumor Treatment Sales Market Share by Application (2021-2026) Table 55. Global FAPI for Tumor Treatment Sales Market Share by Application (2027-2032) Table 56. Global FAPI for Tumor Treatment Price by Application (2021-2026) & (US$/Unit) Table 57. Global FAPI for Tumor Treatment Price by Application (2027-2032) & (US$/Unit) Table 58. Clovis Oncology Company Information Table 59. Clovis Oncology Business Overview Table 60. Clovis Oncology FAPI for Tumor Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Clovis Oncology FAPI for Tumor Treatment Product Portfolio Table 62. Clovis Oncology Recent Development Table 63. Bayer Company Information Table 64. Bayer Business Overview Table 65. Bayer FAPI for Tumor Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Bayer FAPI for Tumor Treatment Product Portfolio Table 67. Bayer Recent Development Table 68. Novartis AG Company Information Table 69. Novartis AG Business Overview Table 70. Novartis AG FAPI for Tumor Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Novartis AG FAPI for Tumor Treatment Product Portfolio Table 72. Novartis AG Recent Development Table 73. North America FAPI for Tumor Treatment Revenue by Type (2021-2026) & (US$ Million) Table 74. North America FAPI for Tumor Treatment Revenue by Type (2027-2032) & (US$ Million) Table 75. North America FAPI for Tumor Treatment Sales by Type (2021-2026) & (K Units) Table 76. North America FAPI for Tumor Treatment Sales by Type (2027-2032) & (K Units) Table 77. North America FAPI for Tumor Treatment Sales Price by Type (2021-2026) & (US$/Unit) Table 78. North America FAPI for Tumor Treatment Sales Price by Type (2027-2032) & (US$/Unit) Table 79. North America FAPI for Tumor Treatment Revenue by Application (2021-2026) & (US$ Million) Table 80. North America FAPI for Tumor Treatment Revenue by Application (2027-2032) & (US$ Million) Table 81. North America FAPI for Tumor Treatment Sales by Application (2021-2026) & (K Units) Table 82. North America FAPI for Tumor Treatment Sales by Application (2027-2032) & (K Units) Table 83. North America FAPI for Tumor Treatment Sales Price by Application (2021-2026) & (US$/Unit) Table 84. North America FAPI for Tumor Treatment Sales Price by Application (2027-2032) & (US$/Unit) Table 85. North America FAPI for Tumor Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 86. North America FAPI for Tumor Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 87. North America FAPI for Tumor Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 88. North America FAPI for Tumor Treatment Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 89. North America FAPI for Tumor Treatment Sales by Country (2021-2026) & (K Units) Table 90. North America FAPI for Tumor Treatment Sales by Country (2027-2032) & (K Units) Table 91. North America FAPI for Tumor Treatment Sales Price by Country (2021-2026) & (US$/Unit) Table 92. North America FAPI for Tumor Treatment Sales Price by Country (2027-2032) & (US$/Unit) Table 93. United States FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 94. Canada FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 95. Mexico FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 96. Europe FAPI for Tumor Treatment Revenue by Type (2021-2026) & (US$ Million) Table 97. Europe FAPI for Tumor Treatment Revenue by Type (2027-2032) & (US$ Million) Table 98. Europe FAPI for Tumor Treatment Sales by Type (2021-2026) & (K Units) Table 99. Europe FAPI for Tumor Treatment Sales by Type (2027-2032) & (K Units) Table 100. Europe FAPI for Tumor Treatment Sales Price by Type (2021-2026) & (US$/Unit) Table 101. Europe FAPI for Tumor Treatment Sales Price by Type (2027-2032) & (US$/Unit) Table 102. Europe FAPI for Tumor Treatment Revenue by Application (2021-2026) & (US$ Million) Table 103. Europe FAPI for Tumor Treatment Revenue by Application (2027-2032) & (US$ Million) Table 104. Europe FAPI for Tumor Treatment Sales by Application (2021-2026) & (K Units) Table 105. Europe FAPI for Tumor Treatment Sales by Application (2027-2032) & (K Units) Table 106. Europe FAPI for Tumor Treatment Sales Price by Application (2021-2026) & (US$/Unit) Table 107. Europe FAPI for Tumor Treatment Sales Price by Application (2027-2032) & (US$/Unit) Table 108. Europe FAPI for Tumor Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Europe FAPI for Tumor Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 110. Europe FAPI for Tumor Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 111. Europe FAPI for Tumor Treatment Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 112. Europe FAPI for Tumor Treatment Sales by Country (2021-2026) & (K Units) Table 113. Europe FAPI for Tumor Treatment Sales by Country (2027-2032) & (K Units) Table 114. Europe FAPI for Tumor Treatment Sales Price by Country (2021-2026) & (US$/Unit) Table 115. Europe FAPI for Tumor Treatment Sales Price by Country (2027-2032) & (US$/Unit) Table 116. Germany FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 117. France FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 118. U.K. FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 119. Italy FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 120. Russia FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 121. Spain FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 122. Netherlands FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 123. Switzerland FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 124. Sweden FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 125. Poland FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 126. China FAPI for Tumor Treatment Revenue by Type (2021-2026) & (US$ Million) Table 127. China FAPI for Tumor Treatment Revenue by Type (2027-2032) & (US$ Million) Table 128. China FAPI for Tumor Treatment Sales by Type (2021-2026) & (K Units) Table 129. China FAPI for Tumor Treatment Sales by Type (2027-2032) & (K Units) Table 130. China FAPI for Tumor Treatment Sales Price by Type (2021-2026) & (US$/Unit) Table 131. China FAPI for Tumor Treatment Sales Price by Type (2027-2032) & (US$/Unit) Table 132. China FAPI for Tumor Treatment Revenue by Application (2021-2026) & (US$ Million) Table 133. China FAPI for Tumor Treatment Revenue by Application (2027-2032) & (US$ Million) Table 134. China FAPI for Tumor Treatment Sales by Application (2021-2026) & (K Units) Table 135. China FAPI for Tumor Treatment Sales by Application (2027-2032) & (K Units) Table 136. China FAPI for Tumor Treatment Sales Price by Application (2021-2026) & (US$/Unit) Table 137. China FAPI for Tumor Treatment Sales Price by Application (2027-2032) & (US$/Unit) Table 138. Asia FAPI for Tumor Treatment Revenue by Type (2021-2026) & (US$ Million) Table 139. Asia FAPI for Tumor Treatment Revenue by Type (2027-2032) & (US$ Million) Table 140. Asia FAPI for Tumor Treatment Sales by Type (2021-2026) & (K Units) Table 141. Asia FAPI for Tumor Treatment Sales by Type (2027-2032) & (K Units) Table 142. Asia FAPI for Tumor Treatment Sales Price by Type (2021-2026) & (US$/Unit) Table 143. Asia FAPI for Tumor Treatment Sales Price by Type (2027-2032) & (US$/Unit) Table 144. Asia FAPI for Tumor Treatment Revenue by Application (2021-2026) & (US$ Million) Table 145. Asia FAPI for Tumor Treatment Revenue by Application (2027-2032) & (US$ Million) Table 146. Asia FAPI for Tumor Treatment Sales by Application (2021-2026) & (K Units) Table 147. Asia FAPI for Tumor Treatment Sales by Application (2027-2032) & (K Units) Table 148. Asia FAPI for Tumor Treatment Sales Price by Application (2021-2026) & (US$/Unit) Table 149. Asia FAPI for Tumor Treatment Sales Price by Application (2027-2032) & (US$/Unit) Table 150. Asia FAPI for Tumor Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. Asia FAPI for Tumor Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 152. Asia FAPI for Tumor Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 153. Asia FAPI for Tumor Treatment Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 154. Asia FAPI for Tumor Treatment Sales by Country (2021-2026) & (K Units) Table 155. Asia FAPI for Tumor Treatment Sales by Country (2027-2032) & (K Units) Table 156. Asia FAPI for Tumor Treatment Sales Price by Country (2021-2026) & (US$/Unit) Table 157. Asia FAPI for Tumor Treatment Sales Price by Country (2027-2032) & (US$/Unit) Table 158. Japan FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 159. South Korea FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 160. India FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 161. Australia FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 162. Taiwan FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 163. Southeast Asia FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 164. SAMEA FAPI for Tumor Treatment Revenue by Type (2021-2026) & (US$ Million) Table 165. SAMEA FAPI for Tumor Treatment Revenue by Type (2027-2032) & (US$ Million) Table 166. SAMEA FAPI for Tumor Treatment Sales by Type (2021-2026) & (K Units) Table 167. SAMEA FAPI for Tumor Treatment Sales by Type (2027-2032) & (K Units) Table 168. SAMEA FAPI for Tumor Treatment Sales Price by Type (2021-2026) & (US$/Unit) Table 169. SAMEA FAPI for Tumor Treatment Sales Price by Type (2027-2032) & (US$/Unit) Table 170. SAMEA FAPI for Tumor Treatment Revenue by Application (2021-2026) & (US$ Million) Table 171. SAMEA FAPI for Tumor Treatment Revenue by Application (2027-2032) & (US$ Million) Table 172. SAMEA FAPI for Tumor Treatment Sales by Application (2021-2026) & (K Units) Table 173. SAMEA FAPI for Tumor Treatment Sales by Application (2027-2032) & (K Units) Table 174. SAMEA FAPI for Tumor Treatment Sales Price by Application (2021-2026) & (US$/Unit) Table 175. SAMEA FAPI for Tumor Treatment Sales Price by Application (2027-2032) & (US$/Unit) Table 176. SAMEA FAPI for Tumor Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. SAMEA FAPI for Tumor Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 178. SAMEA FAPI for Tumor Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 179. SAMEA FAPI for Tumor Treatment Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 180. SAMEA FAPI for Tumor Treatment Sales by Country (2021-2026) & (K Units) Table 181. SAMEA FAPI for Tumor Treatment Sales by Country (2027-2032) & (K Units) Table 182. SAMEA FAPI for Tumor Treatment Sales Price by Country (2021-2026) & (US$/Unit) Table 183. SAMEA FAPI for Tumor Treatment Sales Price by Country (2027-2032) & (US$/Unit) Table 184. Brazil FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 185. Argentina FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 186. Chile FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 187. Colombia FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 188. Peru FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 189. Saudi Arabia FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 190. Israel FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 191. UAE FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 192. Turkey FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 193. Iran FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 194. Egypt FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Table 195. Key Raw Materials Table 196. Raw Materials Key Suppliers Table 197. FAPI for Tumor Treatment Distributors List Table 198. FAPI for Tumor Treatment Customers List Table 199. Research Programs/Design for This Report Table 200. Authors List of This Report Table 201. Secondary Sources Table 202. Primary Sources List of Figures Figure 1. FAPI for Tumor Treatment Image Figure 2. Global FAPI for Tumor Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global FAPI for Tumor Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Beta-emitter Image Figure 5. Alpha-emitter Image Figure 6. Global FAPI for Tumor Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global FAPI for Tumor Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 8. NSCLC Image Figure 9. Pancreatic Cancer Image Figure 10. Breast Cancer Image Figure 11. Others Image Figure 12. Global FAPI for Tumor Treatment Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global FAPI for Tumor Treatment Revenue (2021-2032) & (US$ Million) Figure 14. Global FAPI for Tumor Treatment Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global FAPI for Tumor Treatment Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global FAPI for Tumor Treatment Revenue Market Share by Region (2021-2032) Figure 17. Global FAPI for Tumor Treatment Sales (2021-2032) & (K Units) Figure 18. Global FAPI for Tumor Treatment Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global FAPI for Tumor Treatment Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico FAPI for Tumor Treatment Sales YoY (2021-2032) & (K Units) Figure 21. Europe FAPI for Tumor Treatment Sales YoY (2021-2032) & (K Units) Figure 22. China FAPI for Tumor Treatment Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) FAPI for Tumor Treatment Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa FAPI for Tumor Treatment Sales YoY (2021-2032) & (K Units) Figure 25. Global FAPI for Tumor Treatment Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global FAPI for Tumor Treatment Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global FAPI for Tumor Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global FAPI for Tumor Treatment Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global FAPI for Tumor Treatment Revenue Market Share by Type (2021-2032) Figure 31. Global FAPI for Tumor Treatment Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global FAPI for Tumor Treatment Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global FAPI for Tumor Treatment Sales Market Share by Type (2021-2032) Figure 34. Global FAPI for Tumor Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global FAPI for Tumor Treatment Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global FAPI for Tumor Treatment Revenue Market Share by Application (2021-2032) Figure 37. Global FAPI for Tumor Treatment Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global FAPI for Tumor Treatment Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global FAPI for Tumor Treatment Sales Market Share by Application (2021-2032) Figure 40. North America FAPI for Tumor Treatment Revenue Share by Type (2021-2032) Figure 41. North America FAPI for Tumor Treatment Sales Share by Type (2021-2032) Figure 42. North America FAPI for Tumor Treatment Revenue Share by Application (2021-2032) Figure 43. North America FAPI for Tumor Treatment Sales Share by Application (2021-2032) Figure 44. North America FAPI for Tumor Treatment Revenue Share by Country (2021-2032) Figure 45. North America FAPI for Tumor Treatment Sales Share by Country (2021-2032) Figure 46. Europe FAPI for Tumor Treatment Revenue Share by Type (2021-2032) Figure 47. Europe FAPI for Tumor Treatment Sales Share by Type (2021-2032) Figure 48. Europe FAPI for Tumor Treatment Revenue Share by Application (2021-2032) Figure 49. Europe FAPI for Tumor Treatment Sales Share by Application (2021-2032) Figure 50. Europe FAPI for Tumor Treatment Revenue Share by Country (2021-2032) Figure 51. Europe FAPI for Tumor Treatment Sales Share by Country (2021-2032) Figure 52. China FAPI for Tumor Treatment Revenue Share by Type (2021-2032) Figure 53. China FAPI for Tumor Treatment Sales Share by Type (2021-2032) Figure 54. China FAPI for Tumor Treatment Revenue Share by Application (2021-2032) Figure 55. China FAPI for Tumor Treatment Sales Share by Application (2021-2032) Figure 56. Asia FAPI for Tumor Treatment Revenue Share by Type (2021-2032) Figure 57. Asia FAPI for Tumor Treatment Sales Share by Type (2021-2032) Figure 58. Asia FAPI for Tumor Treatment Revenue Share by Application (2021-2032) Figure 59. Asia FAPI for Tumor Treatment Sales Share by Application (2021-2032) Figure 60. Asia FAPI for Tumor Treatment Revenue Share by Country (2021-2032) Figure 61. Asia FAPI for Tumor Treatment Sales Share by Country (2021-2032) Figure 62. SAMEA FAPI for Tumor Treatment Revenue Share by Type (2021-2032) Figure 63. SAMEA FAPI for Tumor Treatment Sales Share by Type (2021-2032) Figure 64. SAMEA FAPI for Tumor Treatment Revenue Share by Application (2021-2032) Figure 65. SAMEA FAPI for Tumor Treatment Sales Share by Application (2021-2032) Figure 66. SAMEA FAPI for Tumor Treatment Revenue Share by Country (2021-2032) Figure 67. SAMEA FAPI for Tumor Treatment Sales Share by Country (2021-2032) Figure 68. FAPI for Tumor Treatment Value Chain Figure 69. Manufacturing Cost Structure Figure 70. FAPI for Tumor Treatment Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Beta-emitter
  • Alpha-emitter
Applications
  • NSCLC
  • Pancreatic Cancer
  • Breast Cancer
  • Others
Companies covered
  • Clovis Oncology
  • Bayer
  • Novartis AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 FAPI for Tumor Treatment Market by Type
  3. 1.2.1 Global FAPI for Tumor Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Beta-emitter
  5. 1.2.3 Alpha-emitter
  6. 1.3 FAPI for Tumor Treatment Market by Application
  7. 1.3.1 Global FAPI for Tumor Treatment Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 NSCLC
  9. 1.3.3 Pancreatic Cancer
  10. 1.3.4 Breast Cancer
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 FAPI for Tumor Treatment Market Dynamics
  1. 2.1 FAPI for Tumor Treatment Industry Trends
  2. 2.2 FAPI for Tumor Treatment Industry Drivers
  3. 2.3 FAPI for Tumor Treatment Industry Opportunities and Challenges
  4. 2.4 FAPI for Tumor Treatment Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global FAPI for Tumor Treatment Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global FAPI for Tumor Treatment Revenue by Region
  3. 3.2.1 Global FAPI for Tumor Treatment Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global FAPI for Tumor Treatment Revenue by Region (2021-2026)
  5. 3.2.3 Global FAPI for Tumor Treatment Revenue by Region (2027-2032)
  6. 3.2.4 Global FAPI for Tumor Treatment Revenue Market Share by Region (2021-2032)
  7. 3.3 Global FAPI for Tumor Treatment Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global FAPI for Tumor Treatment Sales by Region
  9. 3.4.1 Global FAPI for Tumor Treatment Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global FAPI for Tumor Treatment Sales by Region (2021-2026)
  11. 3.4.3 Global FAPI for Tumor Treatment Sales by Region (2027-2032)
  12. 3.4.4 Global FAPI for Tumor Treatment Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global FAPI for Tumor Treatment Revenue by Manufacturers
  2. 4.1.1 Global FAPI for Tumor Treatment Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global FAPI for Tumor Treatment Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global FAPI for Tumor Treatment Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global FAPI for Tumor Treatment Sales by Manufacturers
  6. 4.2.1 Global FAPI for Tumor Treatment Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global FAPI for Tumor Treatment Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global FAPI for Tumor Treatment Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global FAPI for Tumor Treatment Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global FAPI for Tumor Treatment Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global FAPI for Tumor Treatment Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global FAPI for Tumor Treatment Manufacturers, Product Type & Application
  13. 4.7 Global FAPI for Tumor Treatment Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global FAPI for Tumor Treatment Market CR5 and HHI
  16. 4.8.2 2025 FAPI for Tumor Treatment Tier 1, Tier 2, and Tier 3
5 FAPI for Tumor Treatment Market by Type
  1. 5.1 Global FAPI for Tumor Treatment Revenue by Type
  2. 5.1.1 Global FAPI for Tumor Treatment Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global FAPI for Tumor Treatment Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global FAPI for Tumor Treatment Revenue Market Share by Type (2021-2032)
  5. 5.2 Global FAPI for Tumor Treatment Sales by Type
  6. 5.2.1 Global FAPI for Tumor Treatment Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global FAPI for Tumor Treatment Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global FAPI for Tumor Treatment Sales Market Share by Type (2021-2032)
  9. 5.3 Global FAPI for Tumor Treatment Price by Type
6 FAPI for Tumor Treatment Market by Application
  1. 6.1 Global FAPI for Tumor Treatment Revenue by Application
  2. 6.1.1 Global FAPI for Tumor Treatment Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global FAPI for Tumor Treatment Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global FAPI for Tumor Treatment Revenue Market Share by Application (2021-2032)
  5. 6.2 Global FAPI for Tumor Treatment Sales by Application
  6. 6.2.1 Global FAPI for Tumor Treatment Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global FAPI for Tumor Treatment Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global FAPI for Tumor Treatment Sales Market Share by Application (2021-2032)
  9. 6.3 Global FAPI for Tumor Treatment Price by Application
7 Company Profiles
  1. 7.1 Clovis Oncology
  2. 7.1.1 Clovis Oncology Company Information
  3. 7.1.2 Clovis Oncology Business Overview
  4. 7.1.3 Clovis Oncology FAPI for Tumor Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Clovis Oncology FAPI for Tumor Treatment Product Portfolio
  6. 7.1.5 Clovis Oncology Recent Developments
  7. 7.2 Bayer
  8. 7.2.1 Bayer Company Information
  9. 7.2.2 Bayer Business Overview
  10. 7.2.3 Bayer FAPI for Tumor Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bayer FAPI for Tumor Treatment Product Portfolio
  12. 7.2.5 Bayer Recent Developments
  13. 7.3 Novartis AG
  14. 7.3.1 Novartis AG Company Information
  15. 7.3.2 Novartis AG Business Overview
  16. 7.3.3 Novartis AG FAPI for Tumor Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Novartis AG FAPI for Tumor Treatment Product Portfolio
  18. 7.3.5 Novartis AG Recent Developments
8 North America
  1. 8.1 North America FAPI for Tumor Treatment Market Size by Type
  2. 8.1.1 North America FAPI for Tumor Treatment Revenue by Type (2021-2032)
  3. 8.1.2 North America FAPI for Tumor Treatment Sales by Type (2021-2032)
  4. 8.1.3 North America FAPI for Tumor Treatment Price by Type (2021-2032)
  5. 8.2 North America FAPI for Tumor Treatment Market Size by Application
  6. 8.2.1 North America FAPI for Tumor Treatment Revenue by Application (2021-2032)
  7. 8.2.2 North America FAPI for Tumor Treatment Sales by Application (2021-2032)
  8. 8.2.3 North America FAPI for Tumor Treatment Price by Application (2021-2032)
  9. 8.3 North America FAPI for Tumor Treatment Market Size by Country
  10. 8.3.1 North America FAPI for Tumor Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America FAPI for Tumor Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America FAPI for Tumor Treatment Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe FAPI for Tumor Treatment Market Size by Type
  2. 9.1.1 Europe FAPI for Tumor Treatment Revenue by Type (2021-2032)
  3. 9.1.2 Europe FAPI for Tumor Treatment Sales by Type (2021-2032)
  4. 9.1.3 Europe FAPI for Tumor Treatment Price by Type (2021-2032)
  5. 9.2 Europe FAPI for Tumor Treatment Market Size by Application
  6. 9.2.1 Europe FAPI for Tumor Treatment Revenue by Application (2021-2032)
  7. 9.2.2 Europe FAPI for Tumor Treatment Sales by Application (2021-2032)
  8. 9.2.3 Europe FAPI for Tumor Treatment Price by Application (2021-2032)
  9. 9.3 Europe FAPI for Tumor Treatment Market Size by Country
  10. 9.3.1 Europe FAPI for Tumor Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe FAPI for Tumor Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe FAPI for Tumor Treatment Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China FAPI for Tumor Treatment Market Size by Type
  2. 10.1.1 China FAPI for Tumor Treatment Revenue by Type (2021-2032)
  3. 10.1.2 China FAPI for Tumor Treatment Sales by Type (2021-2032)
  4. 10.1.3 China FAPI for Tumor Treatment Price by Type (2021-2032)
  5. 10.2 China FAPI for Tumor Treatment Market Size by Application
  6. 10.2.1 China FAPI for Tumor Treatment Revenue by Application (2021-2032)
  7. 10.2.2 China FAPI for Tumor Treatment Sales by Application (2021-2032)
  8. 10.2.3 China FAPI for Tumor Treatment Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia FAPI for Tumor Treatment Market Size by Type
  2. 11.1.1 Asia FAPI for Tumor Treatment Revenue by Type (2021-2032)
  3. 11.1.2 Asia FAPI for Tumor Treatment Sales by Type (2021-2032)
  4. 11.1.3 Asia FAPI for Tumor Treatment Price by Type (2021-2032)
  5. 11.2 Asia FAPI for Tumor Treatment Market Size by Application
  6. 11.2.1 Asia FAPI for Tumor Treatment Revenue by Application (2021-2032)
  7. 11.2.2 Asia FAPI for Tumor Treatment Sales by Application (2021-2032)
  8. 11.2.3 Asia FAPI for Tumor Treatment Price by Application (2021-2032)
  9. 11.3 Asia FAPI for Tumor Treatment Market Size by Country
  10. 11.3.1 Asia FAPI for Tumor Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia FAPI for Tumor Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia FAPI for Tumor Treatment Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA FAPI for Tumor Treatment Market Size by Type
  2. 12.1.1 SAMEA FAPI for Tumor Treatment Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA FAPI for Tumor Treatment Sales by Type (2021-2032)
  4. 12.1.3 SAMEA FAPI for Tumor Treatment Price by Type (2021-2032)
  5. 12.2 SAMEA FAPI for Tumor Treatment Market Size by Application
  6. 12.2.1 SAMEA FAPI for Tumor Treatment Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA FAPI for Tumor Treatment Sales by Application (2021-2032)
  8. 12.2.3 SAMEA FAPI for Tumor Treatment Price by Application (2021-2032)
  9. 12.3 SAMEA FAPI for Tumor Treatment Market Size by Country
  10. 12.3.1 SAMEA FAPI for Tumor Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA FAPI for Tumor Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA FAPI for Tumor Treatment Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 FAPI for Tumor Treatment Value Chain Analysis
  2. 13.1.1 FAPI for Tumor Treatment Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 FAPI for Tumor Treatment Production Mode & Process
  6. 13.2 FAPI for Tumor Treatment Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 FAPI for Tumor Treatment Distributors
  9. 13.2.3 FAPI for Tumor Treatment Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst